March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Bilateral Lacrimal Gland Disease: From Docile to Deadly
Author Affiliations & Notes
  • Sunny X. Tang
    Ophthalmology, SUNY Downstate Medical Center, Brooklyn, New York
  • Saad Al-Dahmash
    Ocular Oncology, Wills Eye Institute, Philadelphia, Pennsylvania
    Ophthalmology, King Saud University, College of Medicine, Riyadh, Saudi Arabia
  • Carlos Bianciotto
    Ocular Oncology, Wills Eye Institute, Philadelphia, Pennsylvania
  • Christina H. Choe
    Scheie Eye Institute, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania
  • Todd R. Shepler
    Texas Oculoplastic Consultants, Austin, Texas
  • Edward Wladis
    Lions Eye Institute, Albany, New York
  • Vikram D. Durairaj
    Ophthalmology, University of Colorado Denver School of Medicine, Denver, Colorado
  • Jerry A. Shields
    Ocular Oncology, Wills Eye Institute, Philadelphia, Pennsylvania
  • Carol L. Shields
    Ocular Oncology, Wills Eye Institute, Philadelphia, Pennsylvania
  • Roman Shinder
    Ophthalmology, SUNY Downstate Medical Center, Brooklyn, New York
    Texas Oculoplastic Consultants, Austin, Texas
  • Footnotes
    Commercial Relationships  Sunny X. Tang, None; Saad Al-Dahmash, None; Carlos Bianciotto, None; Christina H. Choe, None; Todd R. Shepler, None; Edward Wladis, None; Vikram D. Durairaj, None; Jerry A. Shields, None; Carol L. Shields, None; Roman Shinder, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 637. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sunny X. Tang, Saad Al-Dahmash, Carlos Bianciotto, Christina H. Choe, Todd R. Shepler, Edward Wladis, Vikram D. Durairaj, Jerry A. Shields, Carol L. Shields, Roman Shinder; Bilateral Lacrimal Gland Disease: From Docile to Deadly. Invest. Ophthalmol. Vis. Sci. 2012;53(14):637.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose:
 

Bilateral lacrimal gland (LG) disease represents a rare presentation with prognoses ranging from innocuous to life-threatening. The literature contains only isolated case reports describing this entity. Here, we present 62 such patients with pathology resulting from inflammatory, infectious, neoplastic, and other etiologies. Clinical presentation, radiography, pathology, & treatment outcomes were assessed.

 
Methods:
 

Retrospective review of 62 cases presenting with bilateral LG disease.

 
Results:
 

Included are 14 males and 48 females with mean age of 47 years (range 10-82, Table 1). In all cases, LG enlargement is clinically evident (Fig 2A), with the disease process either confined to the LG (Fig 2B), or showing orbital extension (Fig 2C). Categories of disease include inflammatory (n=34, 55%), lymphoproliferative (n=16, 26%), prolapsed LG (n=6, 10%), dacryops (n=5, 9%), and extramedullary hematopoiesis (n=1, 2%). Specific diagnoses include idiopathic orbital inflammation (pseudotumor, n=18, 29%), lymphoid tumor (n=16, 26%), sarcoidosis (n=8, 13%), Rosai-Dorfman disease (n=2, 3%), Erdheim-Chester disease (2, 3%), Sjogren’s Disease (2, 3%) and less common entities. Clinical features and outcomes were evaluated.

 
Conclusions:
 

Our findings indicate that bilateral LG disease is most commonly a manifestation of inflammatory and lymphoproliferative diseases. We believe this to be the largest such case series to date and suggest that evaluation and management of bilateral LG disease should focus on the most prevalent diagnoses: pseudotumor, lymphoma, and sarcoidosis.  

 

 
Keywords: lacrimal gland • imaging/image analysis: clinical • orbit 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×